麗江股份(002033.SZ):擬開發玉龍雪山景區甘海子游客集散中心項目
格隆匯3月7日丨麗江股份(002033.SZ)公佈,2022年3月4日,公司第七屆董事會第十五次會議,審議通過了《關於開發玉龍雪山景區甘海子游客集散中心項目的議案》,董事會同意以控股子公司麗江雪川旅遊服務有限公司為實施主體,開發玉龍雪山景區甘海子游客集散中心項目,並授權公司經營班子負責項目的開發實施等工作。
項目選址位於玉龍雪山甘海子5、6號停車場區域,用地規模為24.96畝。項目計劃2022年3月底動工,爭取2022年底完工投入使用。
項目投資金額:項目預計總投資為1.43億元(其中包含建設工程投資1.32億元,土地及原有固定資產總評估值1122.75萬元)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.